TAG:
diagnostic testing
Speculating On How Labs Might Respond to Demo
By Robert Michel | From the Volume XIV No. 18 – December 31, 2007 Issue
CEO SUMMARY: Statements and actions by CMS officials responsible for the laboratory competitive bidding demonstration project reveal the likelihood that they are using it as a Trojan Horse. While talking about implementation of a three-year demonstration project in the San Diego MSA, CMS …
Three Strikes Against CMS Before Bid Demo Begins
By Robert Michel | From the Volume XIV No. 18 – December 31, 2007 Issue
CEO SUMMARY: There’s a touch of irony in the fact that the Medicare program is a national leader in encouraging hospitals, physicians, and other providers to pay greater attention to the voice of patients. Yet within the Centers for Medicare & Medicaid Services (CMS), officials task…
December 31, 2007 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XIV No. 18 – December 31, 2007 Issue
There’s late-breaking news affecting new federal rules for the anti-markup provisions scheduled to become effective on January 1, 2008. Just days ago, the federal Centers for Medicare & Medicaid Services…
Medicare Rules Tighten Anatomic Path Mark-ups
By Robert Michel | From the Volume XIV No. 16 – November 19, 2007 Issue
CEO SUMMARY: Effective on January 1, 2008, new rules take effect that restrict the circumstances under which physicians can mark up the anatomic pathology services provided to their patients. However, ambiguities in how the rules are written are likely to make the intent of the new rules …
Are Feds Ready to Strike at TC/PC Arrangements?
By Robert Michel | From the Volume XIV No. 12 – August 27, 2007 Issue
CEO SUMMARY: Pathologists and laboratory directors will want to pay attention to the proposed rules published by the Centers for Medicare and Medicaid Services on July 2, 2007. The document is a grab bag of proposals and rules that would significantly curb many common ancillary services a…
Siemens Acquires Dade, Builds IVD Powerhouse
By Robert Michel | From the Volume XIV No. 11 – August 6, 2007 Issue
CEO SUMMARY: In just 15 months, Siemens AG has pulled out its checkbook three times to spend more than $14 billion to acquire major in vitro diagnostics (IVD) companies. When it closes the purchase of Dade Behring, Siemens will be in the first rank of global IVD manufacturers. It has also…
Lakewood Pathology Changes Leadership
By Robert Michel | From the Volume XIV No. 10 – July 16, 2007 Issue
CEO SUMMARY: Following the arrival of a new majority owner and a capital commitment of $50 million last year, Lakewood Pathology Associates has taken additional steps to pursue growth. Lakewood plans to acquire small to mid-sized companies that are complementary to its position in the ana…
Global Laboratory Trends Dominated by Rising Costs and Labor Shortage
By Robert Michel | From the Volume XIV No. 9 – June 25, 2007 Issue
“The Web has transformed many industries and it’s clearly affected our industry. This trend will help raise the bar in quality and overall performance among laboratories and manufacturers.” —Jim Reid-Anderson Chairman, President, and CEO of Dade Behring…
Inverness Buys Biosite, Has New Venture with P&G
By Robert Michel | From the Volume XIV No. 8 – June 4, 2007 Issue
CEO SUMMARY: On the same day that Inverness Medical Innovations announced that it would acquire Biosite, thus beating out Beckman Coulter in the bidding war for Biosite, Inverness also announced that it had entered into a joint venture with Procter & Gamble. Together, the two companie…
Why Labs Will Increase their Use of Middleware and Informatics
By Robert Michel | From the Volume XIV No. 6 – April 23, 2007 Issue
“Across the globe, laboratories face similar and significant challenges in how they use information technology and middleware to solve problems.” —Jacques Baudin, Executive Vice President, Technidata America Medical Software CEO SUMMARY: Midd…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized